Search Results - "PECHAN, Peter A"

  • Showing 1 - 14 results of 14
Refine Results
  1. 1
  2. 2

    Free radicals induce gene expression of NGF and bFGF in rat astrocyte culture by Pechan, P A, Chowdhury, K, Seifert, W

    Published in Neuroreport (01-06-1992)
    “…Hydrogen peroxide (H2O2) is a type of active oxygen species produced mainly in blood by inflammation, ischemia or anoxia. Treatment of rat neonatal cortical…”
    Get more information
    Journal Article
  3. 3

    Genetically modified fibroblasts producing NGF protect hippocampal neurons after ischemia in the rat by Pechan, P A, Yoshida, T, Panahian, N, Moskowitz, M A, Breakefield, X O

    Published in Neuroreport (1995)
    “…The neuroprotective effect of nerve growth factor (NGF) on the pyramidal cells in the vulnerable CA1-CA2 sectors of the hippocampus was investigated in a rat…”
    Get more information
    Journal Article
  4. 4

    HSV-1 infected cell proteins influence tetracycline-regulated transgene expression by Herrlinger, Ulrich, Pechan, Peter A., Jacobs, Andreas H., Woiciechowski, Christian, Rainov, Nikolai G., Fraefel, Cornel, Paulus, Werner, Reeves, Steven A.

    Published in The journal of gene medicine (01-09-2000)
    “…Background This study investigates elements of herpes simplex virus type 1 (HSV‐1) which influence transgene expression in tetracycline‐regulated expression…”
    Get full text
    Journal Article
  5. 5

    Combined HSV-1 recombinant and amplicon piggyback vectors: replication-competent and defective forms, and therapeutic efficacy for experimental gliomas by Pechan, Peter A., Herrlinger, Ulrich, Aghi, Manish, Jacobs, Andreas, Breakefield, Xandra O.

    Published in The journal of gene medicine (01-05-1999)
    “…Background The versatility of HSV‐1 vectors includes large transgene capacity, selective replication of mutants in dividing cells, and availability of…”
    Get full text
    Journal Article
  6. 6

    bFGF induces its own gene expression in astrocytic and hippocampal cell cultures by Flott-Rahmel, B, Gerdes, W, Pechan, P A, Brysch, W, Schlingensiepen, K H, Seifert, W

    Published in Neuroreport (01-12-1992)
    “…Basic FGF mRNA induction by bFGF was investigated in cell cultures from rat brain, i.e. postnatal day 2 cortex and embryonic day 18 hippocampus. In situ…”
    Get more information
    Journal Article
  7. 7

    HSV/AAV hybrid amplicon vectors extend transgene expression in human glioma cells by Johnston, K M, Jacoby, D, Pechan, P A, Fraefel, C, Borghesani, P, Schuback, D, Dunn, R J, Smith, F I, Breakefield, X O

    Published in Human gene therapy (10-02-1997)
    “…Novel hybrid vectors, which incorporate critical elements of both herpes simplex virus type 1 (HSV-1) amplicon vectors and adeno-associated virus (AAV)…”
    Get more information
    Journal Article
  8. 8

    Gene therapy for brain tumors by Kramm, C M, Sena-Esteves, M, Barnett, F H, Rainov, N G, Schuback, D E, Yu, J S, Pechan, P A, Paulus, W, Chiocca, E A, Breakefield, X O

    Published in Brain pathology (Zurich, Switzerland) (01-10-1995)
    “…Gene therapy has opened new doors for treatment of neoplastic diseases. This new approach seems very attractive, especially for glioblastomas, since treatment…”
    Get more information
    Journal Article
  9. 9

    A novel 'piggyback' packaging system for herpes simplex virus amplicon vectors by Pechan, P A, Fotaki, M, Thompson, R L, Dunn, R, Chase, M, Chiocca, E A, Breakefield, X O

    Published in Human gene therapy (20-10-1996)
    “…Recombinant and amplicon vectors derived from herpes simplex virus type 1 (HSV-1) have proven to be an efficient means of gene delivery to cells in culture and…”
    Get more information
    Journal Article
  10. 10

    Human fetal astrocytes as an ex vivo gene therapy vehicle for delivering biologically active nerve growth factor by Lin, Q, Cunningham, L A, Epstein, L G, Pechan, P A, Short, M P, Fleet, C, Bohn, M C

    Published in Human gene therapy (10-02-1997)
    “…The therapeutic use of neurotrophic factors for neurodegenerative diseases is promising, however, optimal methods for continuous delivery of these substances…”
    Get more information
    Journal Article
  11. 11

    Herpes vector-mediated delivery of marker genes to disseminated central nervous system tumors by Kramm, C M, Rainov, N G, Sena-Esteves, M, Chase, M, Pechan, P A, Chiocca, E A, Breakefield, X O

    Published in Human gene therapy (10-02-1996)
    “…The present study investigated the ability of a recombinant herpes simplex virus type 1 (HSV) vector to deliver genes into disseminated brain tumor foci…”
    Get more information
    Journal Article
  12. 12

    Long-term survival in a rodent model of disseminated brain tumors by combined intrathecal delivery of herpes vectors and ganciclovir treatment by Kramm, C M, Rainov, N G, Sena-Esteves, M, Barnett, F H, Chase, M, Herrlinger, U, Pechan, P A, Chiocca, E A, Breakefield, X O

    Published in Human gene therapy (20-10-1996)
    “…Brain tumors that have disseminated into cerebrospinal fluid (CSF) pathways are an unresolved therapeutic problem, especially in pediatric neurooncology. Here…”
    Get more information
    Journal Article
  13. 13

    Glutamate induces the growth factors NGF, bFGF, the receptor FGF-R1 and c-fos mRNA expression in rat astrocyte culture by Pechán, P A, Chowdhury, K, Gerdes, W, Seifert, W

    Published in Neuroscience letters (16-04-1993)
    “…The effect of glutamate on primary cultures of rat cortical astrocytes was studied using Northern blot hybridization. Incubation with glutamate (100 microM, 15…”
    Get more information
    Journal Article
  14. 14

    Syngeneic spleen cell immunization induces high mortality among progeny in mice by Pechan, P A

    Published in Teratology (Philadelphia) (01-04-1986)
    “…Syngeneic spleen cell immunization of C57BL/6J females prior to syngeneic matings resulted in significant perinatal and postnatal mortality and increased…”
    Get more information
    Journal Article